Regadenoson Injection, Solution
Product Images NDC 85742-012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 85742-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pfs Carton (Regadenoson Pfs Carton)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) intravenous solution in a single-dose pre-filled syringe. The label includes dosing instructions, storage conditions, barcode, manufacturer name Kanchan Healthcare Inc, and aseptic technique illustrations for syringe use. It is marked Rx only and indicates the product as a pharmacologic stress agent for diagnostic use.*

FDA Label Image

Pfs Label (Regadenoson Pfs Label)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) in a 5 mL single-dose pre-filled syringe. The label indicates intravenous use only, for pharmacologic stress, with discard instructions for unused portions. Manufactured for Indies Pharma Jamaica Limited, made in India, and labeled by Kanchan Healthcare Inc.*

FDA Label Image

Regadenoson-structure (Regadenoson Structure)

Chemical structure diagram of the active ingredient regadenoson, showing its molecular components and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.